No conflicts of interest were declared.
Original Paper
Tumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasis†
Article first published online: 6 JUN 2012
DOI: 10.1002/path.4039
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Additional Information
How to Cite
Uzhachenko, R., Issaeva, N., Boyd, K., Ivanov, S. V., Carbone, D. P. and Ivanova, A. V. (2012), Tumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasis. J. Pathol., 227: 456–469. doi: 10.1002/path.4039
- †
Publication History
- Issue published online: 10 JUL 2012
- Article first published online: 6 JUN 2012
- Accepted manuscript online: 18 APR 2012 06:44AM EST
- Manuscript Accepted: 7 APR 2012
- Manuscript Revised: 4 APR 2012
- Manuscript Received: 14 OCT 2011
Keywords:
- Fus1;
- inflammatory response;
- asbestos;
- DN T cells;
- mitochondria;
- ROS;
- mitochondrial membrane potential;
- UCP2
Abstract
Fus1, encoded by a 3p21.3 tumour suppressor gene, is down-regulated, mutated or lost in the majority of inflammatory thoracic malignancies. The mitochondrial localization of Fus1 stimulated us to investigate how Fus1 modulates inflammatory response and mitochondrial function in a mouse model of asbestos-induced peritoneal inflammation. Asbestos treatment resulted in a decreased Fus1 expression in wild-type (WT) peritoneal immune cells, suggesting that asbestos exposure may compromise the Fus1-mediated inflammatory response. Untreated Fus1−/− mice had an ∼eight-fold higher proportion of peritoneal granulocytes than Fus1+/+ mice, pointing at ongoing chronic inflammation. Fus1−/− mice exhibited a perturbed inflammatory response to asbestos, reflected in decreased immune organ weight and peritoneal fluid protein concentration, along with an increased proportion of peritoneal macrophages. Fus1−/− immune cells showed augmented asbestos-induced activation of key inflammatory, anti-oxidant and genotoxic stress response proteins ERK1/2, NFκB, SOD2, γH2AX, etc. Moreover, Fus1−/− mice demonstrated altered dynamics of pro- and anti-inflammatory cytokine expression, such as IFNγ, TNFα, IL-1A, IL-1B and IL-10. ‘Late’ response cytokine Ccl5 was persistently under-expressed in Fus1−/− immune cells at both basal and asbestos-activated states. We observed an asbestos-related difference in the size of CD3+ CD4− CD8− DN T cell subset that was expanded four-fold in Fus1−/− mice. Finally, we demonstrated Fus1-dependent basal and asbestos-induced changes in major mitochondrial parameters (ROS production, mitochondrial potential and UCP2 expression) in Fus1−/− immune cells and in Fus1-depleted cancer cells, thus supporting our hypothesis that Fus1 establishes its immune- and tumour-suppressive activities via regulation of mitochondrial homeostasis. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

1096-9896/asset/PATH_left.gif?v=1&s=f8845e760fcc5be3e3baa6119dcc01c077e3db22)
1096-9896/asset/PATH_right.gif?v=1&s=86062495907b9532cd169b5a6605dac7fd14f581)
1096-9896/asset/cover.gif?v=1&s=9d27ae473c5444468836a93370dc054fd0ea594f)